AI/ML Innovations Inc. Announces Upcoming Webinar
AI/ML Innovations Inc. Announces Upcoming Webinar
Register here for our live event: AI/ML Innovations Inc. Q2 Recap, Next 90, and Q3 MilestonesVICTORIA, BC / ACCESSWIRE / July 9, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading innovator in Artificial Intelligence and Machine Learning solutions, is pleased to announce an upcoming live webinar event. The webinar is scheduled for July 11th at 9:00 AM PT / 12:00 PM ET and will be broadcast online.
AI/ML創新公司（"AI/ML"或"公司"）（cse:aiml）（otcqb:aimlf）（fwb:42fb）是人工智能和機器學習解決方案領先的創新者，欣然宣佈即將舉行一次在線研討會。研討會定於7月11日上午9:00 Pt / 下午12:00 Et在線播出。
This event will feature Paul Duffy, Chief Executive Officer of AI/ML Innovations Inc., who will provide a comprehensive recap of the past 90 days, an overview of the upcoming 90 days, and outline key Q3 milestones.
本次活動將邀請AI/ML創新公司的首席執行官保羅·達菲提供過去90天的全面回顧，未來90天的概述以及Q3的關鍵里程碑。
We invite all shareholders and interested parties to join us for this informative session.
我們邀請所有股東和感興趣的人蔘加此信息會議。
Register here for our live event: AI/ML Innovations Inc. Q2 Recap, Next 90, and Q3 Milestones
在此註冊我們的現場活動：AI/ML創新公司Q2回顧，未來90天和Q3里程碑
For more information about AI/ML Innovations:
For detailed information please see AI/ML's website or the Company's filed documents at .
執行董事Tim Daniels:
有關詳細信息，請參見AI/ML的網站或公司在...的文件。
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
如需更多信息，請聯繫Blake Fallis，電話：（778）405-0882或電子郵件：info@aiml-innovations.com。
About AI/ML Innovations Inc.
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".
關於人工智能/機器學習創新公司。
更多關於AI/ML創新公司的信息
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
謹代表董事會
AI/ML Innovations Inc.已重新調整其業務運營以利用人工智能（AI）和機器學習（ML）的蓬勃發展，初始投資重點放在利用AI、ML、雲計算和數字平台推動變革性健康管理解決方案和精準支持交付的新興數字健康和健康公司上。通過與健康儀表盤（AIML持有95.2%的所有權）、Tech2Heal（最高持股22%，目前AIML擁有12.44%的所有權）、AI Rx Inc.（AIML持有70%的所有權）和其他計劃中的增值投資進行戰略合作，該公司繼續利用不斷擴大的增長領域，造福於公司的所有利益相關者。AI/ML的股票在加拿大證券交易所上市，代碼爲“AIML”，在OTCQB Venture Market上市，代碼爲“AIMLF”，在Frankfurt Stock Exchange上市，代碼爲“42FB”。
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.
本新聞稿不構成在任何司法管轄區出售或購買任何證券的要約，也不應該有任何在美國任何州出售或購買證券的要約、出售或徵求。
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
CSE及其規則服務提供者（該術語在CSE的政策中定義）不對此公告的充分性或準確性承擔責任。
SOURCE: AI/ML Innovations, Inc.
來源：AI/ML創新公司，Inc.
譯文內容由第三人軟體翻譯。
